Completed NA INTERVENTIONAL 4-arm NCT01288404

Randomized Controlled Trial of Subconjunctival Bevacizumab Injection in Impending Recurrent Pterygium

A Pilot Study of Subconjunctival Bevacizumab Injection in Impending Recurrent Pterygium

Sponsor: Ramathibodi Hospital

Conditions Pterygium of the Conjunctiva and Cornea

Interventions Bevacizumab Fluorometholone

Updated 4 times since 2017 Last updated: Feb 1, 2011 Started: Jan 31, 2008 Primary completion: Sep 30, 2010 Completion: Nov 30, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Pterygium of the Conjunctiva and Cornea and is currently completed. Ramathibodi Hospital leads this study, which shows 4 recorded versions since 2008 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jan 2017 — Jan 2021 [monthly]

Completed NA

First recorded

Jan 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ramathibodi Hospital

Data source: Ramathibodi Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bangkok, Thailand